Surrozen (SRZN) Competitors $10.96 -0.44 (-3.82%) As of 03/28/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SRZN vs. IVA, HURA, GLSI, LRMR, CGEN, ZNTL, ACTU, OGI, SAVA, and DERMShould you be buying Surrozen stock or one of its competitors? The main competitors of Surrozen include Inventiva (IVA), TuHURA Biosciences (HURA), Greenwich LifeSciences (GLSI), Larimar Therapeutics (LRMR), Compugen (CGEN), Zentalis Pharmaceuticals (ZNTL), Actuate Therapeutics (ACTU), Organigram (OGI), Cassava Sciences (SAVA), and Journey Medical (DERM). These companies are all part of the "pharmaceutical products" industry. Surrozen vs. Inventiva TuHURA Biosciences Greenwich LifeSciences Larimar Therapeutics Compugen Zentalis Pharmaceuticals Actuate Therapeutics Organigram Cassava Sciences Journey Medical Inventiva (NASDAQ:IVA) and Surrozen (NASDAQ:SRZN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, community ranking, media sentiment, risk, profitability and institutional ownership. Do analysts rate IVA or SRZN? Inventiva currently has a consensus price target of $12.60, suggesting a potential upside of 329.89%. Surrozen has a consensus price target of $38.50, suggesting a potential upside of 249.68%. Given Inventiva's higher possible upside, analysts plainly believe Inventiva is more favorable than Surrozen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inventiva 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Surrozen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is IVA or SRZN more profitable? Inventiva's return on equity of 0.00% beat Surrozen's return on equity.Company Net Margins Return on Equity Return on Assets InventivaN/A N/A N/A Surrozen N/A -120.51%-54.68% Which has more risk and volatility, IVA or SRZN? Inventiva has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, Surrozen has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500. Does the MarketBeat Community favor IVA or SRZN? Inventiva received 18 more outperform votes than Surrozen when rated by MarketBeat users. Likewise, 82.14% of users gave Inventiva an outperform vote while only 25.00% of users gave Surrozen an outperform vote. CompanyUnderperformOutperformInventivaOutperform Votes2382.14% Underperform Votes517.86%SurrozenOutperform Votes525.00% Underperform Votes1575.00% Do insiders & institutionals have more ownership in IVA or SRZN? 19.1% of Inventiva shares are held by institutional investors. Comparatively, 66.6% of Surrozen shares are held by institutional investors. 32.0% of Inventiva shares are held by company insiders. Comparatively, 43.5% of Surrozen shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has higher earnings and valuation, IVA or SRZN? Surrozen has lower revenue, but higher earnings than Inventiva. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInventiva$15.62M9.85-$119.51MN/AN/ASurrozen$10M3.58-$43.04MN/AN/A Does the media favor IVA or SRZN? In the previous week, Inventiva had 2 more articles in the media than Surrozen. MarketBeat recorded 8 mentions for Inventiva and 6 mentions for Surrozen. Surrozen's average media sentiment score of 1.11 beat Inventiva's score of 0.50 indicating that Surrozen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inventiva 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Surrozen 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryInventiva beats Surrozen on 10 of the 15 factors compared between the two stocks. Remove Ads Get Surrozen News Delivered to You Automatically Sign up to receive the latest news and ratings for SRZN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRZN vs. The Competition Export to ExcelMetricSurrozenBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.78M$3.03B$5.63B$7.84BDividend YieldN/A1.55%5.33%4.01%P/E RatioN/A30.4523.6018.74Price / Sales3.58431.82388.2390.77Price / CashN/A168.6838.1734.64Price / Book0.603.926.894.23Net Income-$43.04M-$71.95M$3.20B$247.47M7 Day Performance-11.57%-5.68%-3.06%-2.29%1 Month Performance-4.01%-12.09%1.52%-5.81%1 Year Performance-29.92%-27.90%9.37%-0.96% Surrozen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRZNSurrozen3.4038 of 5 stars$11.01-3.3%$38.50+249.7%-29.9%$35.78M$10M0.0080Insider TradeNews CoveragePositive NewsGap DownIVAInventiva2.0396 of 5 stars$2.92+3.5%$12.60+331.5%-19.0%$153.23M$15.62M0.00100Analyst ForecastNews CoverageHURATuHURA BiosciencesN/A$3.59+7.8%$13.00+262.1%N/A$151.80MN/A0.00N/AHigh Trading VolumeGLSIGreenwich LifeSciences2.0605 of 5 stars$11.25+1.3%$38.00+237.8%-48.7%$147.88MN/A-14.063News CoverageLRMRLarimar Therapeutics1.9223 of 5 stars$2.28-10.2%$20.13+782.7%-69.0%$145.48MN/A-1.9830Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeCGENCompugen2.0037 of 5 stars$1.62+3.2%$4.00+146.9%-40.7%$144.56M$27.86M81.0070Positive NewsZNTLZentalis Pharmaceuticals1.9184 of 5 stars$1.98+3.7%$8.24+316.4%-88.5%$141.11M$40.56M-0.80160Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageACTUActuate TherapeuticsN/A$7.20+6.7%$20.00+177.8%N/A$140.63MN/A0.0010Gap DownOGIOrganigram0.6899 of 5 stars$1.11flatN/A-52.1%$140.10M$166.12M-2.92860SAVACassava Sciences3.8702 of 5 stars$2.80-1.4%$111.50+3,882.1%-91.9%$137.20MN/A-2.0330Analyst ForecastShort Interest ↓DERMJourney Medical2.5187 of 5 stars$6.54+13.9%$9.67+47.8%+66.0%$136.62M$57.77M-6.9690Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume Remove Ads Related Companies and Tools Related Companies IVA Competitors HURA Competitors GLSI Competitors LRMR Competitors CGEN Competitors ZNTL Competitors ACTU Competitors OGI Competitors SAVA Competitors DERM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRZN) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surrozen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surrozen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SRZN Stock Free SRZN Stock Alerts